CompletedPhase 3NCT01100892
Cystic Fibrosis - Insulin Deficiency, Early Action
Studying Neonatal diabetes mellitus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sydney Children's Hospitals Network
- Principal Investigator
- Charles Verge, MBBS PhDEndocrinology, Sydney Children's Hospital Randwick; School of Women's and Children's Health, University of NSW
- Intervention
- Once-daily insulin detemir(drug)
- Enrollment
- 100 target
- Eligibility
- 5-19 years · All sexes
- Timeline
- 2010 – 2023
Study locations (6)
- Children's Hospital Colorado, Denver, Colorado, United States
- John Hunter Children's Hospital, New Lambton, New South Wales, Australia
- Sydney Children's Hospital, Randwick, New South Wales, Australia
- Children's Hospital at Westmead, Westmead, New South Wales, Australia
- Lady Cilento Children's Hospital, Brisbane, Queensland, Australia
- Women's and Children's Hospital, Adelaide, South Australia, Australia
Collaborators
John Hunter Children's Hospital · Lady Cilento Children's Hospital, Brisbane · Women's and Children's Hospital, Adelaide · Children's Hospital Colorado
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01100892 on ClinicalTrials.govOther trials for Neonatal diabetes mellitus
Additional recruiting or active studies for the same condition.